EW - Company ID 0001099800
The table below shows Edwards Lifesciences Corp's balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $2.94B | $3.05B | $1.14B | $769.00M | $862.80M | $1.18B |
| Short-term investments | $1.29B | $930.70M | $500.50M | $446.30M | $604.00M | $219.40M |
| Receivables | $659.60M | $609.10M | $775.10M | $643.00M | $582.20M | $514.60M |
| Inventory | $1.13B | $1.09B | $1.17B | $875.50M | $726.70M | $802.30M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Total current assets |
| $6.74B |
| $6.29B |
| $4.04B |
| $3.10B |
| $3.18B |
| $3.09B |
| Property, plant & equipment | $1.81B | $1.69B | $1.75B | $1.63B | $1.55B | $1.40B |
| Goodwill | $1.77B | $1.78B | $1.25B | $1.16B | $1.17B | $1.17B |
| Total assets | $13.70B | $13.06B | $9.36B | $8.29B | $8.50B | $7.24B |
| Accounts payable | $227.50M | $197.40M | $201.40M | $201.90M | $204.50M | $196.50M |
| Total current liabilities | $1.81B | $1.51B | $1.20B | $1.02B | $1.03B | $893.90M |
| Long-term debt | $598.30M | $597.70M | $597.00M | $596.30M | $595.70M | $595.00M |
| Total liabilities | $3.36B | $2.99B | $2.64B | $2.49B | $2.67B | - |
| Retained earnings | $14.24B | $13.17B | $8.99B | $7.59B | $6.07B | $4.57B |
| Total equity | $10.34B | $10.00B | $6.65B | $5.81B | $5.84B | $4.57B |